Angela Verardo
Pediatric Endocrinology · Bronx, NYNPI 1164783593
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,174 of the $37,566 with a category attached, or 75.0%. Biomarin Pharmaceutical Inc. accounts for 64.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $27,223 and has fallen 94.2% since, to $1,592 in 2025. Among pediatric endocrinology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $323.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$24K
- AstraZeneca$12K
- Sanofi-aventis U.S. LLC$149
- AbbVie$124
- Novo Nordisk$91
- Dexcom, Inc.$76
- plus $589 from 20 others
What the payments were for
- Consulting fees$2,0676%
- Speaking & faculty fees$28,17475%
- Travel & lodging$4,88113%
- Food & beverage$2,4447%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 41 | $24,059 |
| AstraZeneca | 16 | $12,478 |
| Sanofi-aventis U.S. LLC | 3 | $149 |
| AbbVie | 9 | $124 |
| Novo Nordisk | 6 | $91 |
| Dexcom, Inc. | 5 | $76 |
| Lilly USA, LLC | 5 | $71 |
| Endo Pharmaceuticals Inc. | 4 | $56 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Tandem Diabetes Care, Inc. | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 2 | $36 |
| Kyowa Kirin, Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $31 |
| Tolmar, Inc. | 2 | $31 |
| Tolmar Pharmaceuticals, Inc. | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 2 | $28 |
| Ascendis Pharma Endocrinology Inc | 2 | $27 |
| Rhythm Pharmaceuticals, Inc. | 1 | $26 |
| 180 Medical, Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Pfizer | 1 | $18 |
| Insulet Corporation | 1 | $16 |
| Neurelis, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$11,868
- Strensiq$4,302
- VOXZOGO$2,620
How this compares
$37,566 in reported general payments places this provider in the 90th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Bronx
- Laurie CohenBronx$27K
- Carmen LazalaBronx$6K
- Despoina GaletakiBronx$4K
- Zoltan AntalBronx$2K
- Paul SaengerMineola$180K
- Alicia RomanoSleepy Hollow$157K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Moris AnguloMineola$73K
- Jill BrodskyPoughkeepsie$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.